More News

01 Dec 2020 Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio
28 Nov 2020 Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
23 Nov 2020 Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies
23 Nov 2020 Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb
23 Nov 2020 Horizon Therapeutics plc and Halozyme Therapeutics, Inc. Enter Global Collaboration and License Agreement for ENHANZE® Technology
23 Nov 2020 Merck to Acquire OncoImmune
20 Nov 2020 Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement
19 Nov 2020 ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease
19 Nov 2020 Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes
18 Nov 2020 Caribou Biosciences Announces Licensing Agreement for scFvs Targeting CD371 to Enable Development of Allogeneic Cell Therapies
16 Nov 2020 Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases
12 Nov 2020 MorphoSys and Cherry Biolabs Announce licensing of Hemibody Technology
09 Nov 2020 Infinity Pharmaceuticals Presents New MARIO-1 Phase 1/1b Clinical Data at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
06 Nov 2020 OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis
06 Nov 2020 Artiva Biotherapeutics and Affimed Announce Platform-to-Platform R&D Collaboration for Targeted Off-the-Shelf NK Cell Therapies
06 Nov 2020 Novo Nordisk to acquire Emisphere Technologies and obtain ownership of the Eligen® SNAC oral delivery technology
05 Nov 2020 Merck to Acquire VelosBio
03 Nov 2020 Fusion Pharmaceuticals Announces Collaboration with AstraZeneca to Develop and Commercialize Next-Generation Radiopharmaceuticals and Combination Therapies
02 Nov 2020 Tempus Announces Strategic Collaboration With Janssen Applying Data Science to Enhance Therapeutic Development
02 Nov 2020 Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products
29 Oct 2020 Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company
28 Oct 2020 insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb to Discover and Develop Novel Treatments for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
26 Oct 2020 AnaptysBio and GlaxoSmithKline Amend Strategic Immuno-Oncology Collaboration
23 Oct 2020 Arixa Pharmaceuticals Announces Acquisition by Pfizer’s Hospital Business
23 Oct 2020 Retrophin Announces Agreement to Acquire Orphan Technologies

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up